Janney Montgomery Scott’s Tvardi Therapeutics, Inc. Common Stock TVRD Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2020
Q4 | – | Sell |
-325
| Closed | -$149K | – | 2284 |
|
|
2020
Q3 | $149K | Sell |
325
-38
| -10% | -$17.4K | ﹤0.01% | 1961 |
|
|
2020
Q2 | $223K | Sell |
363
-4
| -1% | -$2.46K | ﹤0.01% | 1780 |
|
|
2020
Q1 | $175K | Sell |
367
-148
| -29% | -$70.6K | ﹤0.01% | 1701 |
|
|
2019
Q4 | $299K | Sell |
515
-63
| -11% | -$36.6K | ﹤0.01% | 1710 |
|
|
2019
Q3 | $380K | Sell |
578
-13
| -2% | -$8.55K | ﹤0.01% | 1553 |
|
|
2019
Q2 | $457K | Sell |
591
-95
| -14% | -$73.5K | ﹤0.01% | 1478 |
|
|
2019
Q1 | $485K | Sell |
686
-118
| -15% | -$83.4K | ﹤0.01% | 1414 |
|
|
2018
Q4 | $376K | Sell |
804
-47
| -6% | -$22K | ﹤0.01% | 1448 |
|
|
2018
Q3 | $734K | Buy |
851
+21
| +3% | +$18.1K | 0.01% | 1224 |
|
|
2018
Q2 | $572K | Sell |
830
-125
| -13% | -$86.1K | 0.01% | 1315 |
|
|
2018
Q1 | $426K | Sell |
955
-636
| -40% | -$284K | ﹤0.01% | 1410 |
|
|
2017
Q4 | $701K | Buy |
1,591
+998
| +168% | +$440K | 0.01% | 1128 |
|
|
2017
Q3 | $292K | Buy |
593
+118
| +25% | +$58.1K | ﹤0.01% | 1513 |
|
|
2017
Q2 | $263K | Sell |
475
-257
| -35% | -$142K | ﹤0.01% | 1500 |
|
|
2017
Q1 | $485K | Sell |
732
-1,190
| -62% | -$788K | 0.01% | 1175 |
|
|
2016
Q4 | $643K | Buy |
1,922
+440
| +30% | +$147K | 0.01% | 975 |
|
|
2016
Q3 | $445K | Sell |
1,482
-1,267
| -46% | -$380K | 0.01% | 1016 |
|
|
2016
Q2 | $476K | Buy |
2,749
+1,384
| +101% | +$240K | 0.01% | 542 |
|
|
2016
Q1 | $306K | Buy |
1,365
+125
| +10% | +$28K | 0.01% | 957 |
|
|
2015
Q4 | $753K | Buy |
1,240
+540
| +77% | +$328K | 0.02% | 644 |
|
|
2015
Q3 | $360K | Buy |
700
+246
| +54% | +$127K | 0.01% | 975 |
|
|
2015
Q2 | $199K | Buy |
454
+104
| +30% | +$45.5K | ﹤0.01% | 1804 |
|
|
2015
Q1 | $127K | Sell |
350
-31
| -8% | -$11.2K | ﹤0.01% | 2249 |
|
|
2014
Q4 | $137K | Buy |
+381
| New | +$137K | ﹤0.01% | 2134 |
|